A detailed history of National Bank Of Canada transactions in Viatris Inc stock. As of the latest transaction made, National Bank Of Canada holds 616,316 shares of VTRS stock, worth $7.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
616,316
Previous 616,316 -0.0%
Holding current value
$7.72 Million
Previous $7.16 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.32 - $12.13 $2.44 Million - $2.87 Million
236,315 Added 62.19%
616,316 $7.16 Million
Q2 2024

Aug 02, 2024

BUY
$10.05 - $12.02 $481,907 - $576,371
47,951 Added 14.44%
380,001 $4.04 Million
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $1.18 Million - $1.42 Million
-104,689 Reduced 23.97%
332,050 $3.96 Million
Q4 2023

Feb 06, 2024

BUY
$8.77 - $10.85 $155,062 - $191,838
17,681 Added 4.22%
436,739 $4.73 Million
Q3 2023

Oct 10, 2023

BUY
$9.59 - $11.35 $670,235 - $793,240
69,889 Added 20.02%
419,058 $4.13 Million
Q2 2023

Jul 26, 2023

BUY
$9.02 - $10.29 $1.14 Million - $1.3 Million
126,803 Added 57.02%
349,169 $3.48 Million
Q1 2023

Apr 12, 2023

SELL
$9.2 - $12.26 $18,887 - $25,169
-2,053 Reduced 0.91%
222,366 $2.14 Million
Q4 2022

Jan 24, 2023

SELL
$8.72 - $11.56 $730,378 - $968,254
-83,759 Reduced 27.18%
224,419 $0
Q3 2022

Oct 13, 2022

SELL
$8.48 - $11.13 $772,935 - $1.01 Million
-91,148 Reduced 22.83%
308,178 $2.66 Million
Q2 2022

Jul 28, 2022

BUY
$9.95 - $12.27 $2.14 Million - $2.63 Million
214,704 Added 116.29%
399,326 $4.2 Million
Q1 2022

May 05, 2022

BUY
$9.81 - $15.4 $229,269 - $359,913
23,371 Added 14.49%
184,622 $2.01 Million
Q4 2021

Jan 24, 2022

BUY
$12.09 - $14.68 $1.95 Million - $2.37 Million
161,251 New
161,251 $2.24 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.